Loading...
Market
Which area of medical research will see the most increased funding due to Brodin's study by September 30, 2025?
2
Resolution / Starting Odds
Gender-affirming therapies • 25%
Immune response studies • 25%
Sex differences in disease susceptibility • 25%
Other • 25%
Funding announcements and reports from research funding organizations
Story
Nature Study by Petter Brodin Finds Testosterone Therapy Alters Immune System in Trans Men
Sep 4, 2024, 03:24 PM
Recent research published in Nature reveals that gender-affirming testosterone therapy in trans men results in significant changes to their immune systems, making them more similar to cisgender men. The study, led by Petter Brodin and colleagues, highlights that testosterone therapy reduces type I interferon and enhances TNF signatures. This research provides insights into why males are more vulnerable to severe infections, such as acute COVID-19, while females are more prone to autoimmune diseases like SLE and MS. The findings, published in Nature, could help scientists better understand sex differences in immune responses among both cisgender and transgender individuals.
View original story
Similar markets
National Institutes of Health (NIH) • 25%
Centers for Disease Control and Prevention (CDC) • 25%
Private Foundations • 25%
Other • 25%
Increased funding for infectious disease research • 25%
Increased funding for chronic disease research • 25%
Increased funding for mental health research • 25%
Other funding priorities • 25%
Pandemic Preparedness • 25%
Chronic Disease Research • 25%
Mental Health Initiatives • 25%
Other • 25%
Yes • 50%
No • 50%
Cardiovascular System • 25%
Hormonal System • 25%
Respiratory System • 25%
Other • 25%
Government grants • 25%
Private investors • 25%
Pharmaceutical companies • 25%
Non-profit organizations • 25%
Increased focus on chronic diseases • 25%
Maintained current balance • 25%
Increased focus on infectious diseases • 25%
No significant changes • 25%
COVID-19 management • 25%
Cancer research • 25%
Mental health • 25%
Other • 25%
Vaccine Development • 25%
Drug Safety • 25%
Food Safety • 25%
Social Safety Net Programs • 25%
Increased funding • 25%
Decreased funding • 25%
Funding remains the same • 25%
No funding • 25%